TBG Terrabiogen Technologies

TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of
proprietary technologies for the production of organic-based, high-value
agricultural products from organic wastes, is pleased to announce that it has
scheduled growing trials at Langara Golf Course in Vancouver.


For several years, TerraBioGen has conducted product field trials on turf
applications with leading institutes such as Cornell University's Department of
Horticulture in Ithaca, New York, which generated very positive results. The
Cornell study demonstrated that the use of TerraBioGen's products allowed up to
a 50% reduction in synthetic fertilizer applications and up to a 75% reduction
in pesticides without impacting turf quality. Highly successful commercial field
trials have simultaneously been conducted at Nicklaus North Golf Course in
Whistler, B.C. The field trial planned for Langara Golf Course in Vancouver
coincides with proposed legislation before the provincial government that would
ban the use of cosmetic pesticides in British Columbia.


Blair Heffelfinger, President and CEO of TerraBioGen stated "These growing
trials are very important and have produced excellent results in the past by
promoting turf quality, suppressing foliar and soil borne disease, and reducing
synthetic fertilizer input requirements. We are pleased to play a role in the
potential ban on cosmetic pesticides by providing an effective, safe,
organically-based alternative."


Jeff MacLean, the Golf Course Superintendent at Langara commented "I am happy to
be working with TerraBioGen once again. The results of our field trials at
Nicklaus North were very encouraging, and these organic products could be a
great fit with the City of Vancouver's commitment to a greener, more sustainable
city. "


About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to
research and development to continue to improve the efficiency of its technology
and the quality of its agricultural products. It is further committed to
developing a worldwide marketing capability to ensure market acceptance of its
products.


This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are statements that are
not historical facts and are generally, but not always, identified by the words
"expects", "plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or conditions
"will", "would", "may", "could" or "should" occur. Although TerraBioGen believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future performance
and actual results may differ materially from those in forward looking
statements. Forward looking statements are based on the beliefs, estimates and
opinions of TerraBioGen's management on the date the statements are made. Except
as required by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.


THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD
IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Terrabiogen Technologies (TSXV:TBG)
Historical Stock Chart
From Oct 2024 to Nov 2024

Terrabiogen Technologies (TSXV:TBG)
Historical Stock Chart
From Nov 2023 to Nov 2024